Published in Biochem Biophys Res Commun on March 31, 1992
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature (2015) 3.24
A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest (2003) 2.37
Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med (2009) 1.72
Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis (1995) 1.46
NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J Cell Biol (1994) 1.12
Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis. Rheumatol Int (2007) 1.01
Dietary patterns of antioxidant vitamin and carotenoid intake associated with bone mineral density: findings from post-menopausal Japanese female subjects. Osteoporos Int (2010) 0.98
Bone mineral density in post-menopausal female subjects is associated with serum antioxidant carotenoids. Osteoporos Int (2007) 0.98
Two different isomers of vitamin e prevent bone loss in postmenopausal osteoporosis rat model. Evid Based Complement Alternat Med (2012) 0.97
Involvement of hydrogen peroxide in the differentiation of clonal HD-11EM cells into osteoclast-like cells. J Cell Physiol (1998) 0.95
High serum carotenoids associated with lower risk for bone loss and osteoporosis in post-menopausal Japanese female subjects: prospective cohort study. PLoS One (2012) 0.93
Differential regulation of HIF-mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts. J Pathol (2013) 0.91
Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases. J Bone Miner Metab (2015) 0.85
Water soluble bioactives of nacre mediate antioxidant activity and osteoblast differentiation. PLoS One (2013) 0.84
Melatonin and the skeleton. Osteoporos Int (2013) 0.81
Glutamate suppresses osteoclastogenesis through the cystine/glutamate antiporter. Am J Pathol (2007) 0.79
Tocotrienol supplementation in postmenopausal osteoporosis: evidence from a laboratory study. Clinics (Sao Paulo) (2013) 0.78
Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption. BMC Complement Altern Med (2013) 0.77
TRP14 inhibits osteoclast differentiation via its catalytic activity. Mol Cell Biol (2014) 0.77
Molecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes. Redox Biol (2016) 0.76
Homocysteine as a Pathological Biomarker for Bone Disease. J Cell Physiol (2016) 0.76
Pathways that Regulate ROS Scavenging Enzymes, and Their Role in Defense Against Tissue Destruction in Periodontitis. Front Physiol (2017) 0.75
Herbs as an antioxidant arsenal for periodontal diseases. J Intercult Ethnopharmacol (2016) 0.75
2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts. Ann Rheum Dis (1995) 0.75
Bone demineralisation in a large cohort of Wilson disease patients. J Inherit Metab Dis (2015) 0.75
Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med (1992) 5.97
Human parvovirus arthropathy. Lancet (1985) 3.76
Self-poisoning: management of patients in Nottingham, 1976. Br Med J (1978) 3.24
Qualitative study of interpretation of reassurance among patients attending rheumatology clinics: "just a touch of arthritis, doctor?". BMJ (2000) 3.05
Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis (1992) 2.63
Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J (1999) 2.62
Simulating sensory-motor incongruence in healthy volunteers: implications for a cortical model of pain. Rheumatology (Oxford) (2005) 2.52
Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett (1998) 2.49
Renal impairment associated with non-steroidal anti-inflammatory drugs. Ann Rheum Dis (1987) 2.48
The importance of iron in rheumatoid disease. Lancet (1981) 2.44
The patient is not a blank sheet: lay beliefs and their relevance to patient education. Br J Rheumatol (1989) 2.42
Continuing worldwide increase in tropospheric methane, 1978 to 1987. Science (1988) 2.30
A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum (1991) 2.18
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut (1994) 2.10
Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum (1996) 2.07
Description of the analysis of a wide range of volatile organic compounds in whole air samples collected during PEM-tropics A and B. Anal Chem (2001) 2.07
Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem (2000) 1.93
Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology (1992) 1.92
Joint stiffness in a phantom limb: evidence of central nervous system involvement in rheumatoid arthritis. Rheumatology (Oxford) (2003) 1.90
Organic aerosol formation downwind from the Deepwater Horizon oil spill. Science (2011) 1.89
Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis. Ann Rheum Dis (1992) 1.77
Mechanism of exacerbation of rheumatoid synovitis by total-dose iron-dextran infusion: in-vivo demonstration of iron-promoted oxidant stress. Lancet (1987) 1.69
A neurogenic mechanism for symmetrical arthritis. Lancet (1989) 1.69
Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial. Neurology (2003) 1.66
Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull (1995) 1.65
Inactivation of the elastase inhibitory activity of alpha 1 antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis (1991) 1.61
Effect of a specific iron chelating agent on animal models of inflammation. Ann Rheum Dis (1983) 1.52
Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol (1998) 1.51
Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J Clin Invest (1985) 1.51
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol (2008) 1.51
Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci U S A (1991) 1.50
Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience (1990) 1.49
Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet (1987) 1.48
Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients. Clin Sci (Lond) (1981) 1.48
Is chronic synovitis an example of reperfusion injury? Ann Rheum Dis (1986) 1.45
Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis (1993) 1.45
Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem Biophys Res Commun (1998) 1.42
Effect of intravenous iron dextran on rheumatoid synovitis. Ann Rheum Dis (1985) 1.41
Photosynthetic control of atmospheric carbonyl sulfide during the growing season. Science (2008) 1.40
Oxygen free radicals, inflammation, and synovitis: and synovitis: the current status. Ann Rheum Dis (1989) 1.40
Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut (1996) 1.39
Measuring outcome in rheumatoid arthritis--which measures are suitable for routine clinical use? Br J Rheumatol (1996) 1.39
Cortical origins of pathological pain. Lancet (2000) 1.39
A controlled pilot study of the utility of mirror visual feedback in the treatment of complex regional pain syndrome (type 1). Rheumatology (Oxford) (2003) 1.38
Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut (1992) 1.36
The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells. Virology (1993) 1.33
Oxidants, inflammation, and anti-inflammatory drugs. FASEB J (1988) 1.32
Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochem J (1991) 1.32
Free radicals in inflammation: second messengers and mediators of tissue destruction. Br Med Bull (1993) 1.30
Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes. Proc Natl Acad Sci U S A (2007) 1.28
Neurogenic influences in arthritis. Ann Rheum Dis (1990) 1.23
A new function for CD38/ADP-ribosyl cyclase in nuclear Ca2+ homeostasis. Nat Cell Biol (1999) 1.23
Restless leg syndrome and rheumatoid arthritis. Br Med J (Clin Res Ed) (1986) 1.22
Cerebral and ocular toxicity induced by desferrioxamine. Q J Med (1985) 1.21
Xanthine oxidoreductase is present in human synovium. Ann Rheum Dis (1987) 1.21
The effect of synovial iron on the progression of rheumatoid disease. A histologic assessment of patients with early rheumatoid synovitis. Arthritis Rheum (1984) 1.20
Hypoxia and inflammatory synovitis: observations and speculation. Ann Rheum Dis (1991) 1.19
Human xanthine oxidase converts nitrite ions into nitric oxide (NO). Biochem Soc Trans (1997) 1.17
Encephalopathy associated with ifosphamide/mesna therapy. Lancet (1985) 1.17
Assessment of iron stores in inflammation by assay of serum ferritin concentrations. Br Med J (Clin Res Ed) (1981) 1.16
Lipid A from endotoxin: antigenic activities of purified fractions in liposomes. J Immunol (1979) 1.16
Synovial fluid ferritin in rheumatoid arthritis. Br Med J (1980) 1.14
Peptides from the calcitonin genes: molecular genetics, structure and function. Biochem J (1988) 1.14
Effects of peptides from the calcitonin genes on bone and bone cells. Q J Exp Physiol (1988) 1.14
Self-poisoning: psychiatric assessment by junior staff. Br Med J (1979) 1.13
Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis (1993) 1.12
Reactive oxygen species and iron--a dangerous partnership in inflammation. Int J Biochem Cell Biol (1995) 1.12
The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copper. Biochem J (1985) 1.11
Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin. FEBS Lett (1992) 1.10
Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption. Br J Cancer (2000) 1.09
Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS. Bone (2002) 1.09
Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis (2003) 1.09
Effect of cigarette smoking on Langerhans' cells. Lancet (1988) 1.08
Allopurinol/N-acetylcysteine for carbon monoxide poisoning. Lancet (1987) 1.08
Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Ann Rheum Dis (1997) 1.08
Breath sulfides and pulmonary function in cystic fibrosis. Proc Natl Acad Sci U S A (2005) 1.08
Superoxide radical generation by inflamed human synovium after hypoxia. Lancet (1989) 1.08
Calcitonin gene-related peptide: potent vasodilator and major product of calcitonin gene. Lancet (1985) 1.08
Free radicals in biological systems--a review orientated to inflammatory processes. Br Med Bull (1987) 1.07
Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neuroscience (1993) 1.07
A comparative evaluation of the metabolic profiles of normal and inflammatory knee-joint synovial fluids by high resolution proton NMR spectroscopy. FEBS Lett (1993) 1.07
Pulsed electromagnetic fields simultaneously induce osteogenesis and upregulate transcription of bone morphogenetic proteins 2 and 4 in rat osteoblasts in vitro. Biochem Biophys Res Commun (1998) 1.06
An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy. FEBS Lett (1993) 1.06
The transcription factors hypoxia-inducible factor 1alpha and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis. Arthritis Rheum (2004) 1.06
Is there excessive use of gastric lavage in the treatment of self-poisoning? Lancet (1979) 1.05
Desensitisation to allopurinol. Ann Rheum Dis (1987) 1.05
Contralateral hyperalgesia and allodynia following intradermal capsaicin injection in man. Rheumatology (Oxford) (2008) 1.04
Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways. J Endocrinol (1990) 1.04
Innervation and neurokinin receptors during angiogenesis in the rat sponge granuloma. Histochem J (1996) 1.04
Circulating antibodies to heat-shock protein 60 in Crohn's disease and ulcerative colitis. Clin Exp Immunol (1992) 1.03